These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2869951)

  • 1. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L; Frithz G
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M; Inagaki Y; Iimura O; Kuramoto K; Takeda T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R; Maclean D; Ioannides C; Johnston A; McDevitt DG
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension.
    Weiner L; Frithz G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S106-12. PubMed ID: 2439780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of treatment with bisoprolol and metoprolol: a randomized multicentre double-blind study (BISOMET).
    Haasis R; Bethge H
    Eur Heart J; 1987 Dec; 8 Suppl M():103-13. PubMed ID: 2967183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of different bisoprolol doses on hemodynamics, plasma catecholamines, platelet aggregation, and alpha 2- and beta-receptors in hypertensive patients.
    Kirsten R; Neff J; Heintz B; Nemeth N; Rahlfs VW; Nelson K
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S113-21. PubMed ID: 2439781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment of left ventricular performance after administration of bisoprolol.
    Esper RJ; Esper RC; Burrieza OH; Menna J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S87-91. PubMed ID: 2439806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pafenolol in hypertension: a double-blind randomized trial of a new beta 1-selective adrenoceptor blocker.
    Dahlöf B; Sjöberg KH; Flygt C; Jern S; Hansen S; Hansson L
    J Cardiovasc Pharmacol; 1986; 8(1):55-9. PubMed ID: 2419693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
    Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
    Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose response studies of bevantolol in hypertensive patients.
    Okawa KK
    Angiology; 1986 Mar; 37(3 Pt 2):233-8. PubMed ID: 2871783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS; Thomas P; Sheridan DJ
    Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
    Bühler FR; Berglund G; Anderson OK; Brunner HR; Scherrer U; van Brummelen P; Distler A; Philipp T; Fogari R; Mimran A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S122-7. PubMed ID: 2439782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: comparative double-blind trial.
    Amabile G; Serradimigni A
    Eur Heart J; 1987 Dec; 8 Suppl M():65-9. PubMed ID: 2967187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension.
    Frithz G; Weiner L
    Eur J Clin Pharmacol; 1987; 32(1):77-80. PubMed ID: 2884116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
    Wagner G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension.
    Asmar RG; Kerihuel JC; Girerd XJ; Safar ME
    Am J Cardiol; 1991 Jul; 68(1):61-4. PubMed ID: 1676238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bisoprolol on cardiac performance in coronary heart disease.
    Maisch B; Borst U; Gerhards W; Wagner G
    Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
    de Muinck E; Wagner G; vd Ven LL; Lie KI
    Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
    Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.